Corporate Profile


Tenax Therapeutics Inc (NASDAQ:TENX)

Tenax Therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients with high unmet medical needs.

Recent News

Investor Relations

Jesse Baumgartner
Stern Investor Relations
212.362.1200
jesse@sternir.com

Management Team

John Kelley
Chief Executive Officer

Michael B. Jebsen
Chief Financial Officer

Paula Bokesch, M.D.
Chief Medical Officer

Douglas Hay, PhD
EVP of Regulatory Affairs

Nancy Hecox
EVP, Legal Affairs, General Counsel, and Corporate Secretary

Doug Randall
EVP of Commercial and Business Operations